149 related articles for article (PubMed ID: 8843473)
21. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
22. [Association between amniotic fluid insulin in the second trimester, maternal glucose tolerance and fetal malformations].
Bühling KJ; Mönnich J; Henrich W; Brauer M; Heinze T; Siebert G; Dudenhausen JW
Z Geburtshilfe Neonatol; 2004 Dec; 208(6):226-31. PubMed ID: 15647986
[TBL] [Abstract][Full Text] [Related]
23. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Eloranta ML; Heinonen S; Kirkinen P
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum alpha-fetoprotein and human chorionic gonadotropin in pregnant women with acute parvovirus B19 infection with and without fetal complications.
Komischke K; Searle K; Enders G
Prenat Diagn; 1997 Nov; 17(11):1039-46. PubMed ID: 9399352
[TBL] [Abstract][Full Text] [Related]
25. Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Burton BK; Dillard RG
Pediatrics; 1986 Apr; 77(4):582-6. PubMed ID: 2421232
[TBL] [Abstract][Full Text] [Related]
26. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
Albright SG; Warner AA; Seeds JW; Burton BK
Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
[TBL] [Abstract][Full Text] [Related]
27. Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption.
Tikkanen M; Hämäläinen E; Nuutila M; Paavonen J; Ylikorkala O; Hiilesmaa V
Prenat Diagn; 2007 Mar; 27(3):240-3. PubMed ID: 17238224
[TBL] [Abstract][Full Text] [Related]
28. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
[TBL] [Abstract][Full Text] [Related]
29. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
[TBL] [Abstract][Full Text] [Related]
30. [Pregnancy complications with abnormal results of biochemical screening for Down syndrome in second trimester and normal fetal karyotype].
Dimitrova V; Chernev T; Vragaleva S; Slŭncheva B; Mikhaĭlova E; Kremenski I; Simeonov E
Akush Ginekol (Sofiia); 2002; 41(6):3-12. PubMed ID: 12577497
[TBL] [Abstract][Full Text] [Related]
31. Relatively reduced values of plasma alpha-fetoprotein at early second trimester of pregnancies with hypertensive disorders.
Leiberman JR; Shoham I; Chattach F; Romem Y; Glezerman M
Am J Perinatol; 1992; 9(5-6):319-21. PubMed ID: 1384520
[TBL] [Abstract][Full Text] [Related]
32. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
Megerian G; Godmilow L; Donnenfeld AE
Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
[TBL] [Abstract][Full Text] [Related]
34. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
35. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome.
Spencer K
Prenat Diagn; 2000 Aug; 20(8):652-6. PubMed ID: 10951476
[TBL] [Abstract][Full Text] [Related]
36. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
37. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
[TBL] [Abstract][Full Text] [Related]
38. Maternal levels of alpha-fetoprotein in African women.
Rogo KO; Onyango GK; Ojwang PJ; Sekkade-Kigondu C
East Afr Med J; 1991 Aug; 68(8):601-5. PubMed ID: 1722453
[TBL] [Abstract][Full Text] [Related]
39. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
[TBL] [Abstract][Full Text] [Related]
40. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]